Guidance: Hepatitis A/B vaccine: patient group direction template

Public Health England

October 31
09:30 2020

HepA/B vaccine PGD

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email tell us what format you need. It will help us if you say what assistive technology you use.


The HepA/B vaccine patient group direction (PGD) supports the provision of HepA/B vaccine to individuals aged one year and over who require pre-exposure immunisation against hepatitis A and B virus.

The HepA/B vaccine PGD v02.00 is valid from 1 November 2019 to 31 October 2021.

Practitioners must not use these PGD templates until they have been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.

These PGD templates should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

The HepA/B vaccine (temp) PGD was withdrawn from 31 October 2020, on its expiry. A subsequent version of this temporary PGD has not been issued since it pertains to recommendations for use during times of monovalent hepatitis vaccine supply shortages. Monovalent hepatitis vaccine supplies are currently considered adequate.

Immunisation patient group direction (PGD) templates for monovalent hepatitis vaccines are available.

Published 13 November 2017
Last updated 31 October 2020 +show all updates
  1. The HepA/B vaccine (temp) PGD was withdrawn from 31 October 2020, on its expiry.

  2. Updated HepA/B vaccine patient group direction (PGD).

  3. Added routine update of the HepA/B vaccine (temp) PGD.

  4. First published.

Related Articles


  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:

Post my comment

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: